发明申请
- 专利标题: PROTEIN FORMULATIONS COMPRISING S1-5
- 专利标题(中): 包含S1-5的蛋白质制剂
-
申请号: US11994327申请日: 2005-12-28
-
公开(公告)号: US20100058488A1公开(公告)日: 2010-03-04
- 发明人: Toshihiro Nakajima , Naoko Yagishita , Tetsuya Amano
- 申请人: Toshihiro Nakajima , Naoko Yagishita , Tetsuya Amano
- 申请人地址: JP Kanagawa
- 专利权人: LOCOMOGENE, INC.
- 当前专利权人: LOCOMOGENE, INC.
- 当前专利权人地址: JP Kanagawa
- 优先权: JPPCT/JP2005/012251 20050701
- 国际申请: PCT/JP2005/024137 WO 20051228
- 主分类号: A01K67/033
- IPC分类号: A01K67/033 ; C12N5/078 ; C12N5/071 ; A01K67/00 ; G01N33/53 ; C07K14/00 ; C07K2/00 ; A61K38/16 ; C07K16/00 ; A61P35/00 ; A61P25/28
摘要:
The present inventors discovered that knockout mice whose S1-5 gene function is lost develop age-related diseases or symptoms. In such knockout mice, bone mineral content, bone mineral density, and bone strength were found to be decreased, and the number of osteoclasts in bone tissues was found to be increased. Analysis of osteoclast-forming ability using bone marrow cells derived from the knockout mice revealed that osteoclast-forming ability is enhanced and osteoclasts are larger in the knockout mice than in wildtype mice. When purified S1-5 protein was added to this in vitro system, osteoclast-forming ability was inhibited. Furthermore, administration of purified S1-5 protein to osteoporotic model mice showed that this protein has the effect of improving osteoporosis. The above findings demonstrate that S1-5 protein is useful for treating and preventing age-related diseases such as osteoporosis.
信息查询